Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FLTM9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,805
Award facts
- Contract value 100% obligated
- $19,804.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,804.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. The award, issued on December 16, 2025, with an ultimate completion date of January 8, 2026, utilizes firm fixed-price pricing with no set-aside designation, allowing the vendor to compete directly against other qualified suppliers. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) designated SPE2DR, awarded under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative on November 13, 2025, with a $499,999,999 ceiling value extending through December 31, 2036.
The PPV-G GEN V represents a $30.3 billion acquisition strategy through which the Defense Logistics Agency establishes regional prime vendor contractors to supply comprehensive pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a prime vendor contractor reflects its demonstrated capability to fulfill specialized pharmaceutical requirements across multiple therapeutic categories and its consistent performance on prior delivery orders. The company maintains no identified subcontractor relationships and operates as the sole awardee under this particular IDC vehicle, positioning it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FLTM9?
SPE2DR26FLTM9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FLTM9 worth?
The government has obligated $19,805 on SPE2DR26FLTM9.
Is contract SPE2DR26FLTM9 an order under another contract?
Yes. SPE2DR26FLTM9 is a delivery order under SPE2DR25D9766, an indefinite delivery contract.
Was contract SPE2DR26FLTM9 competed?
The extent of competition for SPE2DR26FLTM9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award